Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- Have abortion-related laws affected broader access to maternal health care?
- 2/26/2026 10:08:39 AM
- Since 2010, increasing numbers of states across the US have enacted Targeted Regulation of Abortion Providers (TRAP) laws that require abortion clinics to adhere to stringent and often medically unnecessary standards.
- GSMA Foundry and NUHS Singapore to drive 5G and AI innovations in healthcare through new strategic partnership
- 2/26/2026 2:25:42 AM
- The GSMA announced a strategic agreement between GSMA Foundry, the mobile industry’s collaborative innovation hub, and Singapore’s National University Health System (NUHS), a fully integrated academic and regional health system that delivers value-driven, innovative and sustainable healthcare in Singapore.
- ATRO Medical Secures €3 Million to Advance Artificial Meniscus Toward Pivotal Studies
- 2/25/2026 10:03:03 AM
- ATRO Medical, the Dutch clinical-stage orthopedic company developing a novel artificial meniscus implant for patients suffering from post-meniscectomy pain, today announces the successful closing of a €3 million financing round.
- Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis
- 2/24/2026 3:49:45 PM
- • Approval in adults and children aged 6 years and older supported by phase 3 study demonstrating Dupixent significantly reduced nasal signs and symptoms and systemic corticosteroid use or surgery compared to placebo • AFRS is a chronic type 2 inflammatory disease of the sinuses characterized by an allergic hypersensitivity to fungi, often requiring surgery with high …
- Does mental health affect mortality risk in adults with cancer?
- 2/24/2026 11:20:12 AM
- In a study of adults with cancer, those who developed a mental health condition within the first year after their cancer diagnosis had a higher likelihood of dying over the next few years.
- Blackstone Life Sciences Announces a Co-funding Agreement for Acute Myeloid Leukemia
- 2/23/2026 10:46:14 AM
- Blackstone Life Sciences (“BXLS”) today announced a research and development funding agreement to advance the clinical development of bleximenib (JNJ-75276617), an investigational oral menin inhibitor, for acute myeloid leukemia (“AML”).
- Next-generation influenza vaccines could save millions of lives, finds WHO
- 2/20/2026 10:38:03 AM
- Next generation influenza vaccines that provide broader and longer-lasting protection than existing seasonal vaccines, could play a vital role in reducing the global burden of influenza, according to a recent World Health Organization (WHO) assessment.
- Capsadyn® Launches on Amazon, Offering Non-Burning Capsaicin Pain Relief
- 2/19/2026 8:56:39 PM
- Capsadyn®, a non-burning capsaicin cream developed by Chorda Pharma Inc., is now available for purchase on Amazon in addition to direct-to-consumer sales through Capsadyn.com.
- A better approach to preventing chronic conditions
- 2/18/2026 2:21:13 PM
- More than 3 in 4 Americans live with a chronic health condition — many of them preventable. A major reason this crisis continues is that our U.S. health care system focuses more on treatment than on prevention.
- BASF supports European BDO supply security through increased production in Ludwigshafen
- 2/18/2026 1:06:48 PM
- • Increased BDO production ensures reliable and consistent supply to customers across Europe • BASF’s integrated value chain strengthens resilience in key downstream markets • Continued commitment to long‑term European customer partnerships and sustainable product solutions BASF’s Intermediates division is taking decisive steps to further strengthen …
- Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
- 2/18/2026 12:20:10 PM
- • Advanced manufacturing site will utilize cutting‑edge cell therapy technologies to help deliver the company’s portfolio of transformational medicines • Facility will boost Pennsylvania’s economy by creating more than 4,000 construction jobs and 500 biomanufacturing jobs, while further strengthening the Company’s annual $10 billion economic impact across the state …
- Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease
- 2/17/2026 11:24:03 PM
- • In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of induction • Duvakitug was well tolerated and safety was consistent with the induction study • Findings reinforce the potential of duvakitug which is in ongoing phase 3 programs in UC and CD …
- Belén Garijo to become Chief Executive Officer of Sanofi
- 2/12/2026 10:26:35 AM
- Sanofi’s Board of Directors met on February 11, 2026, and decided not to renew the Director mandate of Paul Hudson. As a result, Paul Hudson’s last day as Chief Executive Officer will be on February 17, 2026 at the end of business.
- AdvaMedDx Welcomes Reintroduction of the PASTEUR Act
- 2/12/2026 9:54:43 AM
- AdvaMedDx, the AdvaMed division representing the leading manufacturers of in vitro diagnostic tests, welcomed the reintroduction in the U.S. House of Representatives of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act by Reps.
- Dr. Albert H. Yurvati’s Memoir Series Featured on Texas Billboard
- 2/11/2026 1:33:47 PM
- Dr. Albert H. Yurvati’s four compelling memoirs were prominently featured on a billboard along Golden Triangle Boulevard in Keller, Texas, captivating readers and passersby alike.
- Kaiser Permanente names Mike Bowers president of Northern California Region
- 2/10/2026 11:43:38 AM
- Kaiser Permanente has named Mike Bowers as president of Kaiser Foundation Health Plan and Hospitals in Northern California. Bowers has served as the region’s interim president since February 2025, overseeing operations for 21 hospitals and 203 medical offices, as well as the health care and coverage of 4.6 million Kaiser Permanente members.
- AMA, Vaccine Integrity Project launch vaccine review for next respiratory season
- 2/10/2026 11:42:01 AM
- The Vaccine Integrity Project, in collaboration with the American Medical Association (AMA), today announced the kickoff of a structured, evidence-based review process to assess vaccine safety and effectiveness for the 2026–27 respiratory virus season.
- WHO’s Executive Board reviews progress on Immunization Agenda 2030
- 2/10/2026 10:53:39 AM
- During the 158th session of the WHO Executive Board, 36 Member States, including delegations from each of the WHO regions, and 11 non-State actors acknowledged the continued relevance of the Immunization Agenda 2030 ’s (IA2030) vision to ensure every one, everywhere benefits from life-saving vaccinations.
- Multiple Canadian Healthcare Organizations Select Oracle Health Clinical AI Agent to Help Physicians Spend More Time on Patient Care
- 2/9/2026 3:43:37 AM
- Lumeo Regional Health Information System (Lumeo RHIS) in Southeastern Ontario has selected Oracle Health Clinical AI Agent for a pilot project to streamline clinical documentation and reduce physicians’ administrative workload so they can focus more time on caring for the people they serve.
- “Bride and Blades” Explores the Untold Reality of Surgical Relationships“
- 2/7/2026 12:04:37 AM
- Author Dr. Albert H. Yurvati presents “Bride and Blades: How to Survive a Surgical Marriage,” a revealing book that shines light on the unique challenges of life partnered with a surgeon.